Prednisone Tablet (Boehringer Ingelheim) – Missing Label (2013)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Prednisone Tablet USP, 20 mg tablets, packaged in blisters of ten (10) tablets per blister card, ten blister cards per carton, Roxanne, Columbus, OH --- NDC 0054-0018-20
Brand
Boehringer Ingelheim Roxane Inc
Lot Codes / Batch Numbers
The affected product consists of lot #261739A, expiration date OCT 2014.
Products Sold
The affected product consists of lot #261739A, expiration date OCT 2014.
Boehringer Ingelheim Roxane Inc is recalling Prednisone Tablet USP, 20 mg tablets, packaged in blisters of ten (10) tablets per blister card, ten due to Labeling: Missing Label; missing label on blister card. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Labeling: Missing Label; missing label on blister card
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026